Want to see HK:0557 full AI Analyst Report?
Top Page
China Tian Yuan Healthcare Group Limited
(0557)
Select Model
Select Model
Rating:44Neutral
Price Target:
HK$0.49
▼(-18.33% Downside)
Action:Reiterated
Date:09/27/26
The score is weighed down primarily by weak financial performance—shrinking revenue and persistent operating/net losses—despite moderate leverage and improved recent cash flow. Technicals add pressure with the stock trading below major moving averages and a negative MACD (downtrend), even though the RSI suggests an extremely oversold condition. Valuation is constrained by negative earnings (negative P/E), offering limited support without a dividend yield.
Positive Factors
Manageable Leverage
Debt-to-equity around 0.20–0.24 indicates a relatively conservative funding structure, reducing balance-sheet pressure compared with a highly leveraged model. This gives the company more financial flexibility to manage operations and pursue recovery while profitability remains weak.
Negative Factors
Revenue Contraction
Revenue fell about 27% in 2025 and remains materially below 2021 levels, indicating sustained weakness in top-line momentum. Continued contraction can reduce scale benefits, limit reinvestment capacity, and make it harder to absorb fixed operating costs over the next several quarters.
Read all positive and negative factors
Positive Factors
Negative Factors
Manageable Leverage
Debt-to-equity around 0.20–0.24 indicates a relatively conservative funding structure, reducing balance-sheet pressure compared with a highly leveraged model. This gives the company more financial flexibility to manage operations and pursue recovery while profitability remains weak.
Read all positive factors
China Tian Yuan Healthcare Group Limited (0557) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$199.49M
Dividend YieldN/A
Average Volume (3M)666.00
Price to Earnings (P/E)―
Beta (1Y)-0.88
Revenue Growth50.78%
EPS Growth15.62%
CountryHK
Employees33
SectorFinancial
Sector Strength70
IndustryMedical - Distribution
Share Statistics
EPS (TTM)-0.07
Shares Outstanding398,979,520
10 Day Avg. Volume0
30 Day Avg. Volume666
Financial Highlights & Ratios
PEG Ratio14.08
Price to Book (P/B)1.73
Price to Sales (P/S)14.56
P/FCF Ratio30.63
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
China Tian Yuan Healthcare Group Limited Business Overview & Revenue Model
Company Description
China Tian Yuan Healthcare Group Limited, an investment holding company, provides healthcare related services in Hong Kong, the People's Republic of China, and Korea. It operates through Investment Holding, Healthcare, Money Lending and Related Bu...
China Tian Yuan Healthcare Group Limited Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
58
Neutral
Cash Flow
55
Neutral
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 30.79M | 19.18M | 26.84M | 45.23M | 54.22M | 94.59M |
| Gross Profit | 16.38M | 9.59M | 14.91M | 25.16M | 31.52M | 71.31M |
| EBITDA | 1.65M | -3.51M | -27.22M | -15.79M | -13.08M | -2.89M |
| Net Income | -26.75M | -34.01M | -34.24M | -15.48M | -29.04M | -16.85M |
Balance Sheet | ||||||
| Total Assets | 242.65M | 224.98M | 260.93M | 302.95M | 333.55M | 376.40M |
| Cash, Cash Equivalents and Short-Term Investments | 42.63M | 29.51M | 27.05M | 26.73M | 31.60M | 77.89M |
| Total Debt | 37.46M | 38.72M | 40.77M | 45.91M | 51.13M | 59.66M |
| Total Liabilities | 88.39M | 88.36M | 84.98M | 87.77M | 91.52M | 92.35M |
| Stockholders Equity | 164.09M | 161.22M | 194.68M | 230.26M | 224.30M | 256.25M |
Cash Flow | ||||||
| Free Cash Flow | 4.36M | 9.12M | 10.67M | 4.51M | -31.71M | 14.86M |
| Operating Cash Flow | 4.65M | 9.41M | 10.69M | 5.10M | -30.36M | 16.32M |
| Investing Cash Flow | -292.00K | -292.00K | -3.00K | 364.00K | -1.23M | -1.42M |
| Financing Cash Flow | -2.45M | -5.05M | -10.85M | -8.77M | -12.49M | -7.22M |
China Tian Yuan Healthcare Group Limited Technical Analysis
Negative
0.60
Price Trends
0.53
Negative
0.55
Negative
0.58
Negative
Market Momentum
>-0.01
Negative
3.46
Positive
79.20
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0557, the sentiment is Negative. The current price of 0.6 is above the 20-day moving average (MA) of 0.50, above the 50-day MA of 0.53, and above the 200-day MA of 0.58, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 3.46 is Positive, neither overbought nor oversold. The STOCH value of 79.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0557.
China Tian Yuan Healthcare Group Limited Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | HK$1.67B | 16.93 | 2.28% | 2.16% | 3.53% | -7.42% | |
68 Neutral | HK$782.46M | 2.54 | 8.45% | 5.53% | 6.80% | 67.22% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
62 Neutral | HK$518.93M | 13.81 | 0.90% | 0.77% | 6.29% | ― | |
60 Neutral | HK$1.56B | 4.56 | 3.55% | 7.27% | 5.13% | 585.92% | |
47 Neutral | HK$377.49M | -0.79 | -7.36% | 3.48% | 49.29% | 79.61% | |
44 Neutral | HK$199.49M | -7.05 | -16.34% | ― | 50.78% | 15.62% |
* Financial Sector Average
HK:0557
China Tian Yuan Healthcare Group Limited
0.50
-0.38
-43.18%
HK:0184
Keck Seng Investments (Hong Kong)
2.30
0.12
5.31%
HK:1270
Langham Hospitality Investments
0.44
-0.01
-2.87%
HK:0201
Magnificent Hotel Investments Limited
0.06
-0.01
-17.14%
HK:1221
Sino Hotels (Holdings) Ltd.
1.39
>-0.01
-0.29%
HK:0078
Regal Hotels International Holdings Limited
0.42
-0.21
-33.33%
China Tian Yuan Healthcare Group Limited Corporate Events
China Tian Yuan Healthcare Swings to Interim Profit on Surging Revenue
Aug 28, 2026
China Tian Yuan Healthcare Group Limited reported a sharp improvement in its interim performance for the six months ended 30 June 2026, with revenue climbing to HK$20.0 million from HK$8.4 million a year earlier. The group swung to an unaudited co...
China Tian Yuan Healthcare Schedules Board Meeting on Interim Results and Dividend
Aug 14, 2026
China Tian Yuan Healthcare Group Limited is a Cayman Islands-incorporated healthcare group listed in Hong Kong and focused on medical and healthcare services. Its board consists of an executive director, a non-executive director and three independ...
China Tian Yuan Healthcare Wins Unanimous Backing at 2026 AGM
Jun 29, 2026
China Tian Yuan Healthcare Group Limited reported that all resolutions tabled at its 29 June 2026 annual general meeting were approved by shareholders via poll. The meeting confirmed the receipt of the 2025 reports and financial statements, unders...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.